Recruiting Fabry Disease Studies in Cincinnati
About Fabry Disease Clinical Trials in Cincinnati
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 3 fabry disease clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 48 participants. Research is being sponsored by Chiesi Farmaceutici S.p.A., GC Biopharma Corp, Amicus Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in Cincinnati — FAQ
Are there fabry disease clinical trials in Cincinnati?
Yes, there are 3 fabry disease clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cincinnati?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.
Are clinical trials in Cincinnati free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 3 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated July 19, 2026 from ClinicalTrials.gov